Daiichi Sankyo to Present More Than 30 Research Abstracts at ESMO
Daiichi Sankyo says it will present more than 30 abstracts, including four late-breaking presentations, at the 2026 ESMO Congress. The research spans its oncology portfolio and multiple cancers.